BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32504762)

  • 1. Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines.
    Mir R; Kelly SM; Xiao Y; Moore A; Clark CH; Clementel E; Corning C; Ebert M; Hoskin P; Hurkmans CW; Ishikura S; Kristensen I; Kry SF; Lehmann J; Michalski JM; Monti AF; Nakamura M; Thompson K; Yang H; Zubizarreta E; Andratschke N; Miles E
    Radiother Oncol; 2020 Sep; 150():30-39. PubMed ID: 32504762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials.
    Yang H; Mir R; Díez P; Tsang Y; Conibear J; Simões R; Cox S; Webster A; Nabi Z; Eaton D; Naismith O; Whilde N; Miles E
    Clin Oncol (R Coll Radiol); 2020 Feb; 32(2):e60-e66. PubMed ID: 31607614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: An ASTRO Consensus Paper.
    Wright JL; Yom SS; Awan MJ; Dawes S; Fischer-Valuck B; Kudner R; Mailhot Vega R; Rodrigues G
    Pract Radiat Oncol; 2019 Mar; 9(2):65-72. PubMed ID: 30576843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials.
    Melidis C; Bosch WR; Izewska J; Fidarova E; Zubizarreta E; Ulin K; Ishikura S; Followill D; Galvin J; Haworth A; Besuijen D; Clark CH; Miles E; Aird E; Weber DC; Hurkmans CW; Verellen D
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1242-9. PubMed ID: 25539374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Multi-Institutional Prospective Peer Review on Target and Organ-at-Risk Delineation in Radiation Therapy.
    Riegel AC; Vaccarelli M; Cox BW; Chou H; Cao Y; Potters L
    Pract Radiat Oncol; 2019 Mar; 9(2):e228-e235. PubMed ID: 30415075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in the contouring of organs at risk: test case from a patient with oropharyngeal cancer.
    Nelms BE; Tomé WA; Robinson G; Wheeler J
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):368-78. PubMed ID: 21123004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of an automated EPTN-consensus based organ at risk atlas in the brain on MRI.
    Crouzen JA; Petoukhova AL; Wiggenraad RGJ; Hutschemaekers S; Gadellaa-van Hooijdonk CGM; van der Voort van Zyp NCMG; Mast ME; Zindler JD
    Radiother Oncol; 2022 Aug; 173():262-268. PubMed ID: 35714807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-Based Upper Abdominal Organs-at-Risk Atlas for Radiation Oncology.
    Lukovic J; Henke L; Gani C; Kim TK; Stanescu T; Hosni A; Lindsay P; Erickson B; Khor R; Eccles C; Boon C; Donker M; Jagavkar R; Nowee ME; Hall WA; Parikh P; Dawson LA
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):743-753. PubMed ID: 31953061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of deviations in target volume delineation - Time for a new RTQA approach?
    Cox S; Cleves A; Clementel E; Miles E; Staffurth J; Gwynne S
    Radiother Oncol; 2019 Aug; 137():1-8. PubMed ID: 31039468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group.
    Nielsen MH; Berg M; Pedersen AN; Andersen K; Glavicic V; Jakobsen EH; Jensen I; Josipovic M; Lorenzen EL; Nielsen HM; Stenbygaard L; Thomsen MS; Vallentin S; Zimmermann S; Offersen BV;
    Acta Oncol; 2013 May; 52(4):703-10. PubMed ID: 23421926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assurance tool for organ at risk delineation in radiation therapy using a parametric statistical approach.
    Hui CB; Nourzadeh H; Watkins WT; Trifiletti DM; Alonso CE; Dutta SW; Siebers JV
    Med Phys; 2018 May; 45(5):2089-2096. PubMed ID: 29481703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.
    Ng M; Leong T; Chander S; Chu J; Kneebone A; Carroll S; Wiltshire K; Ngan S; Kachnic L
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1455-62. PubMed ID: 22401917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated contouring error detection based on supervised geometric attribute distribution models for radiation therapy: a general strategy.
    Chen HC; Tan J; Dolly S; Kavanaugh J; Anastasio MA; Low DA; Li HH; Altman M; Gay H; Thorstad WL; Mutic S; Li H
    Med Phys; 2015 Feb; 42(2):1048-59. PubMed ID: 25652517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving automatic delineation for head and neck organs at risk by Deep Learning Contouring.
    van Dijk LV; Van den Bosch L; Aljabar P; Peressutti D; Both S; J H M Steenbakkers R; Langendijk JA; Gooding MJ; Brouwer CL
    Radiother Oncol; 2020 Jan; 142():115-123. PubMed ID: 31653573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cranial organs at risk delineation: heterogenous practices in radiotherapy planning.
    Vogin G; Hettal L; Bartau C; Thariat J; Claeys MV; Peyraga G; Retif P; Schick U; Antoni D; Bodgal Z; Dhermain F; Feuvret L
    Radiat Oncol; 2021 Feb; 16(1):26. PubMed ID: 33541394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology.
    Eekers DB; In 't Ven L; Roelofs E; Postma A; Alapetite C; Burnet NG; Calugaru V; Compter I; Coremans IEM; Høyer M; Lambrecht M; Nyström PW; Méndez Romero A; Paulsen F; Perpar A; de Ruysscher D; Renard L; Timmermann B; Vitek P; Weber DC; van der Weide HL; Whitfield GA; Wiggenraad R; Troost EGC;
    Radiother Oncol; 2018 Jul; 128(1):37-43. PubMed ID: 29548560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open RT Structures: A Solution for TG-263 Accessibility.
    Anderson BM; Padilla L; Ryckman JM; Covington E; Hong DS; Woods K; Katz MS; Zuhour R; Estes C; Moore KL; Bojechko C
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):859-863. PubMed ID: 37778423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical Trials.
    Gerhard SG; Palma DA; Arifin AJ; Louie AV; Li GJ; Al-Shafa F; Cheung P; Rodrigues GB; Bassim CW; Corkum MT
    Pract Radiat Oncol; 2021; 11(4):e355-e365. PubMed ID: 34217495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology.
    Eekers DBP; Di Perri D; Roelofs E; Postma A; Dijkstra J; Ajithkumar T; Alapetite C; Blomstrand M; Burnet NG; Calugaru V; Compter I; Coremans IEM; Harrabi S; Iannalfi A; Klaver YLB; Lambrecht M; Romero AM; Paulsen F; Timmermann B; Vitek P; van der Weide HL; Whitfield GA; Nyström PW; Zindler J; de Ruysscher D; Langendijk J; Weber DC; Troost EGC
    Radiother Oncol; 2021 Jul; 160():259-265. PubMed ID: 34015385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is accurate contouring of salivary and swallowing structures necessary to spare them in head and neck VMAT plans?
    Delaney AR; Dahele M; Slotman BJ; Verbakel WFAR
    Radiother Oncol; 2018 May; 127(2):190-196. PubMed ID: 29605479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.